1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review. - Escalante Romero, L.; Queiroz Costa Neto, I.; Antunes, V.L.J.; Matos Correia Rodrigues, M.; Polo Mercado, J.R.; Monteiro Caran, E. (Annals of Oncology, 2024)